Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 439,138 shares at $6.98 ($3.2M) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Seasonal sale ($3.2M) by CEO and Chairman — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.98 | 81,206 | $567K | 17.7% |
| 2 | $6.98 | 81,206 | $567K | 17.7% |
| 3 | $6.99 | 36,145 | $253K | 7.9% |
| 4 | $6.99 | 36,145 | $253K | 7.9% |
| 5 | $7.64 | 102,218 | $781K | 24.4% |
| 6 | $7.64 | 102,218 |
| $781K |
| 24.4% |
| Total | $7.29 avg | 439,138 | $3.2M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |